Beurs gesloten -
Nasdaq
22:30:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3,327
USD
|
+1,42%
|
|
-4,68%
|
-18,47%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
78,76
|
698,4
|
198,5
|
41,44
|
42,17
|
41,06
|
-
|
-
|
Bedrijfswaarde
1 |
78,76
|
698,4
|
198,5
|
41,44
|
42,17
|
41,06
|
41,06
|
41,06
|
K/w-verhouding
|
-4,5
x
|
-37,3
x
|
-6,32
x
|
-1,45
x
|
-2,25
x
|
-2,48
x
|
-3,22
x
|
-4,5
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
150
x
|
29,1
x
|
5,06
x
|
4,61
x
|
3,75
x
|
2,09
x
|
1,23
x
|
Bedrijfswaarde/omzet
|
-
|
150
x
|
29,1
x
|
5,06
x
|
4,61
x
|
3,75
x
|
2,09
x
|
1,23
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-45.875.974
x
|
-
|
-1.278.349
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
6.483
|
6.939
|
7.475
|
8.306
|
10.337
|
12.344
|
-
|
-
|
Referentieprijs
2 |
12,15
|
100,6
|
26,55
|
4,989
|
4,080
|
3,327
|
3,327
|
3,327
|
Datum van publicatie
|
26/03/20
|
25/03/21
|
23/03/22
|
22/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
4,651
|
6,812
|
8,184
|
9,154
|
10,96
|
19,67
|
33,47
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-17,98
|
-
|
-32,76
|
-18,85
|
-17,29
|
-15,42
|
-10,08
|
Operationele Marge
|
-
|
-386,61%
|
-
|
-400,35%
|
-205,94%
|
-157,7%
|
-78,39%
|
-30,13%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-17,9
|
-
|
-27,17
|
-16,69
|
-15,9
|
-12,2
|
-7,6
|
Nettowinst (verlies)
1 |
-15,24
|
-17,9
|
-
|
-27,17
|
-16,69
|
-17,26
|
-15,39
|
-10,07
|
Nettomarge
|
-
|
-384,97%
|
-
|
-331,99%
|
-182,32%
|
-157,47%
|
-78,23%
|
-30,1%
|
WPA
2 |
-2,700
|
-2,700
|
-4,200
|
-3,450
|
-1,810
|
-1,343
|
-1,033
|
-0,7400
|
Free Cash Flow
|
-
|
-15,22
|
-
|
-32,42
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-327,33%
|
-
|
-396,1%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
26/03/20
|
25/03/21
|
23/03/22
|
22/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
1,666
|
1,851
|
1,893
|
-
|
2,072
|
2,153
|
2,316
|
2,491
|
2,217
|
2,13
|
2,411
|
2,746
|
2,783
|
3,027
|
3,1
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-9,691
|
-
|
-9,247
|
-
|
-9,697
|
-5,601
|
-5,769
|
-4,321
|
-4,116
|
-4,135
|
-4,319
|
-4,301
|
-4,423
|
-4,481
|
-
|
Operationele Marge
|
-581,69%
|
-
|
-488,48%
|
-
|
-468%
|
-260,15%
|
-249,09%
|
-173,46%
|
-185,66%
|
-194,13%
|
-179,18%
|
-156,61%
|
-158,92%
|
-148,02%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-9,707
|
-
|
-9,268
|
-
|
-4,558
|
-5,101
|
-6,067
|
-2,317
|
-4,706
|
-3,089
|
-4
|
-4
|
-3,9
|
-4
|
-
|
Nettowinst (verlies)
1 |
-9,707
|
-
|
-9,268
|
-8,243
|
-4,558
|
-5,101
|
-6,067
|
-2,317
|
-4,706
|
-3,089
|
-4,304
|
-4,297
|
-4,42
|
-4,473
|
-
|
Nettomarge
|
-582,65%
|
-
|
-489,59%
|
-
|
-219,98%
|
-236,93%
|
-261,96%
|
-93,01%
|
-212,27%
|
-145,02%
|
-178,55%
|
-156,47%
|
-158,83%
|
-147,77%
|
-
|
WPA
2 |
-1,350
|
-1,200
|
-1,200
|
-1,050
|
-0,6000
|
-0,6000
|
-0,7300
|
-0,2800
|
-0,4800
|
-0,3000
|
-0,3367
|
-0,3100
|
-0,2967
|
-0,2800
|
-0,2200
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
10/11/21
|
23/03/22
|
11/05/22
|
10/08/22
|
10/11/22
|
22/03/23
|
15/05/23
|
14/08/23
|
13/11/23
|
28/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-15,2
|
-
|
-32,4
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
0,49
|
-
|
0,23
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
10,54%
|
-
|
2,83%
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
26/03/20
|
25/03/21
|
23/03/22
|
22/03/23
|
28/03/24
|
-
|
-
|
-
|
Laatste slotkoers
3,327
USD Gemiddelde koersdoel
3,3
USD Spread / Gemiddelde doel -0,80% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -18,47% | 41,06 mln. | | -20,45% | 10,82 mld. | | +43,17% | 3,25 mld. | | -35,86% | 2,11 mld. | | -17,21% | 2,08 mld. | | -29,81% | 1,48 mld. | | +17,56% | 1,02 mld. | | -4,37% | 733 mln. | | -37,00% | 391 mln. | | -46,94% | 383 mln. |
Bio-diagnostiek & testen
|